{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:06:59Z","timestamp":1771034819817,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302826"],"award-info":[{"award-number":["81302826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473280"],"award-info":[{"award-number":["81473280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bcp.2017.09.016","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T20:05:44Z","timestamp":1507665944000},"page":"127-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury"],"prefix":"10.1016","volume":"146","author":[{"given":"Xiaoguang","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenqing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.09.016_b0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2017.09.016_b0010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.28128","article-title":"Risk stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists","volume":"63","author":"Trivedi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0020","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.29019","article-title":"Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","article-title":"Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis","volume":"60","author":"Wunsch","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0035","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1080\/14656566.2016.1218471","article-title":"Obeticholic acid for the treatment of primary biliary cholangitis","volume":"17","author":"Ali","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bcp.2017.09.016_b0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2017.09.016_b0045","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: a metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2017.09.016_b0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbalip.2010.04.006","article-title":"Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease","volume":"1801","author":"Gadaleta","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2017.09.016_b0055","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2017.09.016_b0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/j.gastro.2015.02.037","article-title":"Targeting the FXR nuclear receptor to treat liver disease","volume":"148","author":"Neuschwander-Tetri","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2017.09.016_b0065","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/gast.2002.36587","article-title":"Functional expression of the canalicular bile salt export pump of human liver","volume":"123","author":"Noe","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2017.09.016_b0070","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/mp300178a","article-title":"Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins","volume":"9","author":"Herraez","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2017.09.016_b0075","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","article-title":"Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics","volume":"130","author":"Ho","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2017.09.016_b0080","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/hep.21878","article-title":"Hepatocyte growth factor signaling pathway inhibits cholesterol 7alpha-hydroxylase and bile acid synthesis in human hepatocytes","volume":"46","author":"Song","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.taap.2015.01.020","article-title":"Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis","volume":"283","author":"Meng","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2017.09.016_b0090","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/hep.25905","article-title":"Promotion of liver regeneration\/repair by farnesoid X receptor in both liver and intestine in mice","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0095","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/hep.25918","article-title":"Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice","volume":"56","author":"Borude","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0100","doi-asserted-by":"crossref","first-page":"33453","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2017.09.016_b0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.taap.2016.11.006","article-title":"Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation","volume":"314","author":"Zhang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2017.09.016_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2017.01.007","article-title":"Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation","volume":"378","author":"Zhang","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2017.09.016_b0115","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1039\/C7SC00055C","article-title":"Dynamic, structural and thermodynamic basis of insulin-like growth factor 1 kinase allostery mediated by activation loop phosphorylation","volume":"8","author":"Li","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bcp.2017.09.016_b0120","doi-asserted-by":"crossref","first-page":"188101","DOI":"10.1103\/PhysRevLett.90.188101","article-title":"Energy landscape theory, funnels, specificity, and optimal criterion of biomolecular binding","volume":"90","author":"Wang","year":"2003","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.bcp.2017.09.016_b0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/jpet.105.097758","article-title":"Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor","volume":"317","author":"Deng","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2017.09.016_b0130","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bcp.2009.06.026","article-title":"The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease","volume":"78","author":"Mencarelli","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.09.016_b0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jhep.2010.12.037","article-title":"Insufficient bile acid signaling impairs liver repair in CYP27(\u2212\/\u2212) mice","volume":"55","author":"Meng","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2017.09.016_b0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bcp.2014.09.009","article-title":"Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor","volume":"92","author":"Meng","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.09.016_b0145","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0150","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2017.09.016_b0155","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0091270007299930","article-title":"Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs","volume":"47","author":"Urquhart","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2017.09.016_b0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.apsb.2015.01.005","article-title":"Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration","volume":"5","author":"Li","year":"2015","journal-title":"Acta Pharm. Sinica B"},{"key":"10.1016\/j.bcp.2017.09.016_b0165","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bph.13729","article-title":"Schisandrol B protects against cholestatic liver injury through pregnane X receptors","volume":"174","author":"Zeng","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.09.016_b0170","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/dmd.113.056549","article-title":"Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins","volume":"42","author":"Chen","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2017.09.016_b0175","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/me.2009-0286","article-title":"FXR regulates liver repair after CCl4-induced toxic injury","volume":"24","author":"Meng","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2017.09.016_b0180","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1053\/j.gastro.2011.02.055","article-title":"PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts","volume":"140","author":"He","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217306135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217306135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T04:01:30Z","timestamp":1535342490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217306135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"alternative-id":["S0006295217306135"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.09.016","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}